164 related articles for article (PubMed ID: 16180940)
1. Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reporting.
Hedenmalm K; Samuelsson E
Drug Saf; 2005; 28(10):907-16. PubMed ID: 16180940
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome.
Hedenmalm K; Samuelsson E; Spigset O
Acta Obstet Gynecol Scand; 2004 Jun; 83(6):576-85. PubMed ID: 15144341
[TBL] [Abstract][Full Text] [Related]
3. Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying rates.
Samuelsson E; Hedenmalm K; Persson I
Eur J Epidemiol; 2005; 20(6):509-16. PubMed ID: 16121760
[TBL] [Abstract][Full Text] [Related]
4. [Venous thromboembolism and combined oral contraceptives. Reported adverse reactions indicate at least similar risk with the most recent contraceptive pills].
Kieler H; Persson I; Odlind V
Lakartidningen; 2003 Sep; 100(39):3050-2. PubMed ID: 14560670
[TBL] [Abstract][Full Text] [Related]
5. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
Samuelsson E; Hägg S
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
Farmer RD; Lawrenson RA; Todd JC; Williams TJ; MacRae KD; Tyrer F; Leydon GM
Br J Clin Pharmacol; 2000 Jun; 49(6):580-90. PubMed ID: 10848722
[TBL] [Abstract][Full Text] [Related]
7. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
8. Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol.
Lidegaard Ø
J Obstet Gynaecol Can; 2003 Jul; 25(7):575-7. PubMed ID: 12851669
[TBL] [Abstract][Full Text] [Related]
9. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
Schink T; Princk C; Braitmaier M; Haug U
BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
[TBL] [Abstract][Full Text] [Related]
10. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
[TBL] [Abstract][Full Text] [Related]
11. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database.
Farmer RD; Lawrenson RA; Todd JC; Williams TJ; MacRae K
Hum Reprod Update; 1999; 5(6):688-706. PubMed ID: 10652979
[TBL] [Abstract][Full Text] [Related]
13. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Odlind V; Milsom I; Persson I; Victor A
Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
[TBL] [Abstract][Full Text] [Related]
17. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
[TBL] [Abstract][Full Text] [Related]
18. Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill.
Black C; Kaye JA; Jick H
Br J Clin Pharmacol; 2002 Jun; 53(6):637-40. PubMed ID: 12047488
[TBL] [Abstract][Full Text] [Related]
19. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
20. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]